Revision: Jan. 24, 2023, 11:28 a.m.
SB 240 - AS INTRODUCED
2023 SESSION
23-0991
05/04
SENATE BILL 240
AN ACT relative to conditions for genetic testing.
SPONSORS: Sen. Prentiss, Dist 5; Sen. Perkins Kwoka, Dist 21; Sen. Watters, Dist 4; Sen. Fenton, Dist 10; Rep. Cormen, Graf. 15; Rep. Morse, Graf. 9
COMMITTEE: Health and Human Services
-----------------------------------------------------------------
ANALYSIS
This bill permits disclosure of genetic testing or genetic analysis to clinical entities participating in processes related to clinical care of the patient or to clinical research.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
23-0991
05/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Three
AN ACT relative to conditions for genetic testing.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Conditions of Genetic Testing. Amend RSA 141-H:2, IV to read as follows:
IV. Nothing in this section shall be construed to regulate or apply to genetic testing or genetic analysis used for diagnosis and treatment of a patient by a clinical laboratory that has received a specimen referral from the individual patient's treating physician, genetic counselor, or another clinical laboratory. Nothing in this section shall be construed so as to waive the requirement that the treating physician obtain specific informed consent in accordance with the provisions of this section. This section shall not prohibit the disclosure of genetic testing or genetic analysis to clinical entities participating in processes related to clinical care of the patient or to clinical research.
2 Effective Date. This act shall take effect 60 days after its passage.